SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001013594-24-000200
Filing Date
2024-02-14
Accepted
2024-02-14 16:38:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 arbutus13ga1-02142024.htm SC 13G/A 76828
  Complete submission text file 0001013594-24-000200.txt   78600
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Subject) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-85963 | Film No.: 24639448
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 12 E. 49TH STREET 40TH FLOOR NEW YORK NY 10017
Business Address 12 E. 49TH STREET 40TH FLOOR NEW YORK NY 10017 2122594370
Whitefort Capital Management, LP (Filed by) CIK: 0001884931 (see all company filings)

IRS No.: 820808818 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A